Characterization of Insufficient Responders to Ustekinumab in Patients With Moderate-to-Severe Psoriasis in the US Corrona Psoriasis Registry.

Characterization of Insufficient Responders to Ustekinumab in Patients With Moderate-to-Severe Psoriasis in the US Corrona Psoriasis Registry. Article

sustainable development goals

SDG 03: Good Health and Well-being

authors

Van Voorhees, Abby S.

publication date

2020

published in

JOURNAL OF DERMATOLOGICAL TREATMENT Journal

keywords

Corrona Psoriasis Registry
Psoriasis
effectiveness
ustekinumab